- Home
- NVS vs GS Comparison
NVS vs GS Comparison
Compare NVS & GS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVS
- GS
- Stock Information
- Founded
- NVS 1895
- GS 1869
- Country
- NVS Switzerland
- GS United States
- Employees
- NVS N/A
- GS N/A
- Industry
- NVS Biotechnology: Pharmaceutical Preparations
- GS Investment Bankers/Brokers/Service
- Sector
- NVS Health Care
- GS Finance
- Exchange
- NVS Nasdaq
- GS Nasdaq
- Market Cap
- NVS 242.8B
- GS 226.9B
- IPO Year
- NVS 1991
- GS 1999
- Fundamental
- Price
- NVS $126.51
- GS $745.12
- Analyst Decision
- NVS Hold
- GS Buy
- Analyst Count
- NVS 6
- GS 14
- Target Price
- NVS $123.67
- GS $664.69
- AVG Volume (30 Days)
- NVS 1.3M
- GS 1.6M
- Earning Date
- NVS 10-28-2025
- GS 10-14-2025
- Dividend Yield
- NVS 2.05%
- GS 2.15%
- EPS Growth
- NVS N/A
- GS 45.80
- EPS
- NVS 6.85
- GS 45.34
- Revenue
- NVS $55,186,000,000.00
- GS $54,794,000,000.00
- Revenue This Year
- NVS $9.01
- GS $12.38
- Revenue Next Year
- NVS $2.49
- GS $4.90
- P/E Ratio
- NVS $17.93
- GS $16.44
- Revenue Growth
- NVS 12.95
- GS 12.06
- 52 Week Low
- NVS $96.06
- GS $439.38
- 52 Week High
- NVS $128.03
- GS $753.33
- Technical
- Relative Strength Index (RSI)
- NVS 63.71
- GS 59.24
- Support Level
- NVS $125.82
- GS $733.86
- Resistance Level
- NVS $127.07
- GS $753.33
- Average True Range (ATR)
- NVS 1.20
- GS 13.01
- MACD
- NVS 0.34
- GS 0.27
- Stochastic Oscillator
- NVS 84.31
- GS 82.24
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. Key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States comprising close to one third of total revenue.
About GS Goldman Sachs Group Inc. (The)
Goldman Sachs is a storied financial institution, founded in 1869 and best known for its role as a leading global investment bank. The firm has a sprawling reach across global financial centers and has been the leading provider of global merger and acquisition advisory services, by revenue, for the past 20 years. Since the global financial crisis, Goldman has expanded its offerings into more stable fee-based businesses like asset and wealth management, which comprised roughly 30% of post-provision revenue at the end of 2024. The bank holding company generates revenue from investment banking, global market making and trading, lending, asset management, wealth management, and a small and declining portfolio of consumer credit card loans.